This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kushner, M. J. Search for Related Content PubMed PubMed Citation Articles by Kushner, M. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

Stroke, Vol 21, 295-298, Copyright © 1990 by American Heart Association

ARTICLES

Prospective study of anticardiolipin antibodies in stroke

MJ Kushner
Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia 19104.

Over 2 years, 104 patients underwent clinical evaluation and laboratory screening for the presence of abnormal anticardiolipin antibodies to determine the profile of laboratory and clinical findings in patients with stroke and other neurologic disorders. Seven with incomplete or ambiguous data were excluded; of the remaining 97 patients, 31 were greater than or equal to 65 years old. Nine patients suffered systemic lupus erythematosus, 45 suffered brain ischemia, and 43 suffered other nonischemic neurologic disorders. Cardiac arrhythmia, myocardial infarction, and cardiac valvulopathy were grounds for exclusion. The presence of anticardiolipin antibodies was not influenced by age. In the 88 patients without lupus, anticardiolipin antibodies were significantly more common in the group suffering brain ischemia than in the group with nonischemic neurologic disorders (29% versus 5%, p less than 0.01, chi 2 test). These controlled data demonstrate an association between the presence of circulating anticardiolipin antibodies with stroke, but not with other neurologic conditions.

This article has been cited by other articles:

				S. Quenby, R.G. Farquharson, F. Dawood, A.M. Hughes, and J. Topping Recurrent miscarriage and long-term thrombosis risk: a case-control study Hum. Reprod., June 1, 2005; 20(6): 1729 - 1732. [Abstract] [Full Text] [PDF]

				R L Brey, J Chapman, S R Levine, G Ruiz-Irastorza, R H. Derksen, M Khamashta, and Y Shoenfeld Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 Lupus, July 1, 2003; 12(7): 508 - 513. [Abstract] [PDF]

				M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood, March 1, 2003; 101(5): 1827 - 1832. [Abstract] [Full Text] [PDF]

				R. L. Brey, C. L. Stallworth, D. L. McGlasson, M. A. Wozniak, R. J. Wityk, B. J. Stern, M. A. Sloan, R. Sherwin, T. R. Price, R. F. Macko, et al. Antiphospholipid Antibodies and Stroke in Young Women * Editorial Comment Stroke, October 1, 2002; 33(10): 2396 - 2401. [Abstract] [Full Text] [PDF]

				R. L. Brey, R. D. Abbott, J. D. Curb, D. S. Sharp, G. W. Ross, C. L. Stallworth, and S. J. Kittner {beta}2-Glycoprotein 1-Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction: The Honolulu Heart Program Stroke, August 1, 2001; 32(8): 1701 - 1706. [Abstract] [Full Text] [PDF]

				S. Tuhrim, J. H. Rand, X. Wu, D. R. Horowitz, J. Weinberger, M. E. Goldman, and J. H. Godbold Antiphosphatidyl serine antibodies are independently associated with ischemic stroke Neurology, October 22, 1999; 53(7): 1523 - 1523. [Abstract] [Full Text] [PDF]

				S. Tuhrim, J. H. Rand, X.-X. Wu, J. Weinberger, D. R. Horowitz, M. E. Goldman, and J. H. Godbold Elevated Anticardiolipin Antibody Titer Is a Stroke Risk Factor in a Multiethnic Population Independent of Isotype or Degree of Positivity Stroke, August 1, 1999; 30(8): 1561 - 1565. [Abstract] [Full Text] [PDF]

				G. Rivier, M. T. Herranz, M. A. Khamashta, and G. R.V. Hughes Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments Lupus, April 1, 1994; 3(2): 85 - 90. [Abstract] [PDF]